|
Showing 1 - 2 of
2 matches in All Departments
Leading oncologists, hematologists, and nephrologists
comprehensively review the role of HGFs in clinical practice,
explain the molecular basis of their effects, and consider
potential future developments. The authors focus on the use of HGFs
in oncology, describing their cutting-edge application to patients
with lung cancer, Hodgkin's and nonhodgkin's lymphoma, breast
cancer, chronic lymphocytic leukemia, AIDS-related malignancies,
myelodysplastic syndromes, and aplastic anemias. Among the HGFs
described are granulocyte colony-stimulating factor, erythropoietc
factors, thrombopoietic factors, and stem cell factor and its
receptor, C-kit. To complete their survey, the contributors also
consider the safety and economic implications of HGFs and the
future potential for HGF antagonists in oncology.
Leading oncologists, hematologists, and nephrologists
comprehensively review the role of HGFs in clinical practice,
explain the molecular basis of their effects, and consider
potential future developments. The authors focus on the use of HGFs
in oncology, describing their cutting-edge application to patients
with lung cancer, Hodgkin's and nonhodgkin's lymphoma, breast
cancer, chronic lymphocytic leukemia, AIDS-related malignancies,
myelodysplastic syndromes, and aplastic anemias. Among the HGFs
described are granulocyte colony-stimulating factor, erythropoietc
factors, thrombopoietic factors, and stem cell factor and its
receptor, C-kit. To complete their survey, the contributors also
consider the safety and economic implications of HGFs and the
future potential for HGF antagonists in oncology.
|
You may like...
Hampstead
Diane Keaton, Brendan Gleeson, …
DVD
R66
Discovery Miles 660
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
|